Table 1.
Variable name | Normalized score (%) | Full gene name | Overlap with known gene sets | Adj p-value (from DEG analysis) | KS test | |
---|---|---|---|---|---|---|
Statistic | p-value | |||||
RETN | 100 | Resistin | PERSEVERE (14) | 6.65 × 10−5 | 0.44 | 2.08 × 10−7 |
IL1R2 | 100 | Interleukin 1 Receptor Type 2 | Sweeney et al. (17) | 1 × 10−4 | 0.34 | 1 × 10−4 |
PRISM Score** | 100 | Not applicable | Not applicable | Not applicable | 0.46 | 3.08 × 10−8 |
SDC4*# | 100 | Syndecan-4 | Nikaido et al. (48) | 1.93 × 10−10 | 0.49 | 3.98 × 10−9 |
TGFBI | 100 | Transforming Growth Factor Beta Induced | PERSEVERE XP (15), Sweeney et al. (17) | 1.36 × 10−5 | 0.41 | 1.15 × 10−6 |
CEACAM8 | 96 | CEA Cell Adhesion Molecule 8 | Sweeney et al. (17) | 1 × 10−4 | 0.44 | 1.35 × 10−7 |
MMP8 | 92 | Matrix metalloproteinase-8 | PERSEVERE (14) | 2 × 10−4 | 0.39 | 4.51 × 10−6 |
ELANE (ELA2) | 92 | Elastase, Neutrophil Expressed | PERSEVERE (14) | 2 × 10−3 | 0.37 | 1.59 × 10−5 |
CLEC5A* | 92 | C-Type Lectin Domain Containing 5A | 8.87 × 10−5 | 0.37 | 2.35 × 10−5 | |
TCN1* | 92 | Transcobalamin 1 | 1 × 10−4 | 0.39 | 6.59 × 10−6 | |
CEP55 | 92 | Centrosomal Protein 55 | PERSEVERE XP (15), Sweeney et al. (17) | 3.78 × 10−6 | 0.40 | 2.20 × 10−6 |
MME | 92 | Membrane Metalloendopeptidase | PERSEVERE XP (15) | 2 × 10−4 | 0.39 | 4 × 10−6 |
MS4A3* | 92 | Membrane Spanning 4-Domains A3 | 7 × 10−3 | 0.34 | 1 × 10−4 | |
DEFA4 | 92 | Defensin Alpha 4 | Sweeney et al. (17) | 5.8 × 10−2 | 0.30 | 1 × 10−3 |
HCAR3* | 88 | Hydroxycarboxylic Acid Receptor 3 | Kangelaris et al. (49) | 2 × 10−3 | 0.33 | 1 × 10−4 |
LCN2 | 88 | Lipocalin-2 | PERSEVERE (14) | 9.6 × 10−5 | 0.39 | 3.8 × 10−6 |
OLAH* | 84 | Oleoyl-ACP Hydrolase Olfactomedin 4 | Basu et al. (50) | 1.1 × 10−2 | 0.31 | 6 × 10−4 |
OLFM4 | 68 | Olfactomedin 4 | Basu et al. (50) | 1.8 × 10−3 | 0.33 | 1 × 10−4 |
LTF | 68 | Lactoferrin | PERSEVERE (14) | 3.9 × 10−3 | 0.34 | 9.5 × 10−5 |
PLCB1*# | 68 | Phospholipase C Beta 1 | 0.3 | 1 × 10−4 | ||
NLRP1*# | 68 | NLR Family Pyrin Domain Containing 1 | 2.56 × 10−6 | 0.45 | 5.41 × 10−8 |
Novel genes.
Non-DEGs.
Clinical variable. Novel Biomarkers are indicated in bold.